Used in biomedical research to quantify UDP-glucuronosyltransferase (UGT) enzyme activity in mouse samples, particularly in liver and other tissues involved in drug metabolism. Helps assess the impact of drugs, toxins, or genetic modifications on phase II metabolic pathways. Widely applied in pharmacokinetic studies, toxicology assessments, and evaluation of drug-drug interactions in preclinical mouse models. Enables high-throughput screening of compounds that induce or inhibit UGT enzymes, supporting drug development and safety testing.